Details for New Drug Application (NDA): 061810
✉ Email this page to a colleague
NDA 061810 describes CANDEX, which is a drug marketed by Bayer Pharms and is included in two NDAs. Additional details are available on the CANDEX profile page.
The generic ingredient in CANDEX is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
The generic ingredient in CANDEX is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for 061810
| Tradename: | CANDEX |
| Applicant: | Bayer Pharms |
| Ingredient: | nystatin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061810
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 100,000 UNITS/GM | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
